Search Results
Results found for "Brian Arey"
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
protein intake setpoint in Drosophila Kappa Opioid Receptor Activation Induces Epigenetic Silencing of Brain-Derived
- GPCR Happy Hour – Boston, Sept 2025
Their areas of focus include structural biology, protein production from Proteos, and nanoparticle characterization worldwide in identifying and optimizing new therapeutic opportunities across a wide range of disease areas
- đź“° GPCR Weekly News, January 30 to February 5, 2023
Reviews, GPCRs, and more Understanding Neuropeptide Transmission in the Brain by Optical Uncaging and
- Immunomodulatory Role of Neuropeptides in the Cornea
As research in this area expands, further insights are made into the role of neuropeptides and their However, progress in this area has led to an increase in studies that have begun modulating neuropeptide
- Ben Clements on Rescuing Opioids with GPCR Modulators
Ben’s approach injects new life into an area most clinicians have given up on.
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
implicated in the pathophysiology of Alzheimer's disease (AD), biased GPCR signaling is a largely unexplored area determined that G protein-biased signaling reduces soluble Aβ levels and leads to a decrease in the area
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Practical approaches to evaluating and optimizing brain exposure in early drug discovery. serotonin 5-HT2A receptor inverse agonism for Gαi1- and neutral antagonism for Gαq/11-proteins in human brain
- Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for ...
discover novel small molecules targeting G-Protein Coupled Receptors (GPCRs) in a metabolic disease area
- The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology
in the peripheral nervous system and in central circuits like the prefrontal cortex and thalamus  — areas
- Diversification of PAR signaling through receptor crosstalk
We will discuss recent evidence as well as what we consider as emerging areas to explore; from the signalling
- Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
distributed to support third party research, but the group also does its own research into promising therapy areas
- G protein-coupled receptor signaling: transducers and effectors
first summarize their prominent roles in GPCR pharmacology before transitioning into less well-explored areas
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
led to more than 700 approved drugs over previous decades—but the two-year-old biotech believes the area
- Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update
2023 and continue to evaluate the path forward for dipraglurant in a number of interesting disease areas
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
These effects include reducing the atherosclerotic plaque area, improving the serum lipid profile, attenuation
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
These effects include reducing the atherosclerotic plaque area, improving the serum lipid profile, attenuation
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. LĂĽbeck, Germany...
GPCRs have been associated with various disease-specific manifestations, highlighting a potential new area
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
has extensive experience across all phases of clinical development, and across multiple therapeutic areas
- Dr. GPCR and GeneTex Partner to Engage the Community on Anti-GPCR Antibody Challenges
GeneTex develops antibodies and reagents supporting a broad range of biomedical research areas, with
- GPCRS: AN ODYSSEY FROM STRUCTURE, SIGNALING AND REGULATION TO THERAPEUTICS
interdisciplinary group of scientists to exchange new experimental data, technologies and ideas in the following areas
- How GPCR Collaboration Built an Innovation Engine
This design had a strategic effect : talent density increased, but so did interdisciplinary surface area
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
Papasergi-Scott and colleagues has made significant progress in this area 2.
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
early discovery or clinical development, the strategies here could open doors in your own therapeutic area
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
iterative process of continuous, planned improvement ensures you're always addressing the next critical area
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
The cross-talk between growth factor receptors and GPCRs is an intriguing area of study.
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
dominate failure statistics, but fundamental blind spots still derail programs Every therapeutic area—CNS
- Curve Shifts Don’t Lie, But Your Eyes Might
What used to be a gray area— “maybe these lines are different?”
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
In conclusion, GPCR priming represents a compelling area of research that promises to deepen our understanding
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
In summary, dimerization in class B1 GPCRs is an emerging area of research that has far-reaching implications
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
veterinary sedative never intended for human use, is infiltrating the opioid supply in cities and rural areas













